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Calcitriol, the bioactive metabolite of vitamin D, interacts with the ubiquitously
expressed nuclear vitamin D receptor (VDR) to induce genomic effects, but it can
also elicit rapid responses via membrane-associated VDR through mechanisms that
are poorly understood. The down-regulation of K+ currents is the main origin of
electrophysiological remodeling in pathological hypertrophy and heart failure (HF), which
can contribute to action potential prolongation and subsequently increase the risk of
triggered arrhythmias. Adult mouse ventricular myocytes were isolated and treated with
10 nM calcitriol or vehicle for 15–30 min. In some experiments, cardiomyocytes were
pretreated with the Akt inhibitor triciribine. In the adult mouse ventricle, outward K+
currents involved in cardiac repolarization are comprised of three components: the
fast transient outward current (Itof), the ultrarapid delayed rectifier K+ current (Ikur), and
the non-inactivating steady-state outward current (Iss). K+ currents were investigated
using the whole-cell or the perforated patch-clamp technique and normalized to cell
capacitance to obtain current densities. Calcitriol treatment of cardiomyocytes induced
an increase in the density of Itof and Ikur, which was lost in myocytes isolated from VDR-
knockout mice. In addition, calcitriol activated Akt in cardiomyocytes and pretreatment
with triciribine prevented the calcitriol-induced increase of outward K+ currents. In
conclusion, we demonstrate that calcitriol via VDR and Akt increases both Itof and
Ikur densities in mouse ventricular cardiomyocytes. Our findings may provide new
mechanistics clues for the cardioprotective role of this hormone in the heart.
Keywords: calcitriol, potassium currents, cardiomyocytes, vitamin D, cellular electrophysiology, ionic channel
remodeling, Akt
INTRODUCTION
Cardiac remodeling is the response of the heart to various damaging stimuli, such as long
standing hypertension or myocardial infarction. This physiological process is characterized by
the triggering of “compensatory” pathways such as, the renin-angiotensin system (RAS) and the
sympathetic nervous system (SNS). Initially, this mechanism is beneficial but sustained activation
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of neurohormonal systems can cause additional damage to the
heart, commonly in the form of hypertrophy, apoptosis and
fibrosis, contributing to the adverse remodeling process, and
accelerating the transition toward heart failure (HF) (Heusch
et al., 2014; Hartupee and Mann, 2017). Moreover, ventricular
remodeling modifies the functioning of ion channels and
transporters such as that cardiac rhythm disturbances occur,
which is termed “arrhythmogenic remodeling” (Nattel et al.,
2007). K+ currents play key roles in shaping the action potentials
(APs), and adverse ventricular remodeling induces down-
regulation of several K+ currents, which are associated with
prolonged QT intervals, increased risk of malignant arrhythmias
and sudden cardiac death. It is well known that almost one-half
of HF patients die from sudden cardiac death, most probably due
to ventricular arrhythmias (Nass et al., 2008; Lehnart et al., 2009).
Vitamin D deficiency is highly prevalent worldwide, an in
particular among the elderly population (Holick, 2007). Low
levels of vitamin D have been associated with worse outcomes
in patients with HF (Liu et al., 2011; Gotsman et al., 2012)
and vitamin D supplementation has been shown to ameliorate
symptoms and decrease mortality (Gotsman et al., 2012; Witte
et al., 2016). The biologically active form of vitamin D is
1,25-dihydroxycholecalciferol or calcitriol, which translocates the
cell membrane and cytoplasm to reached the nucleus of the
cell, where it binds to vitamin D receptor (VDR). In turn,
VDR can bind to retinoic X receptor to serve as a nuclear
transcription factors, regulating the expression of numerous
genes. In addition to these genomic responses, calcitriol can
mediate rapid responses by binding to cell membrane VDR,
interacting with ion channels (Menegaz et al., 2011; Zanatta
et al., 2012; Tamayo et al., 2017) and membrane-based signaling
pathways (Larriba et al., 2014).
Previous reports have postulated that activation of the PI3K
pathway can modulate cardiac K+ channels in cardiomyocytes
(Yang et al., 2012; Gomez-Hurtado et al., 2014) and Akt is a well-
known target of PI3K, activated by calcitriol in other cellular
systems.
Calcitriol has been demonstrated to initiate a VDR-dependent
rapid activation of PI3K/Akt signaling in osteoblasts (Vertino
et al., 2005). In addition, the anti-apoptotic properties of calcitriol
in osteoblasts are thought to be related to the non-genomic
activation of a VDR/PI3K/Akt pathway (Zhang and Zanello,
2008). Moreover, activation of Akt by calcitriol has also been
observed in leukemia, squamous cell carcinoma and skeletal
muscle cells (Ma et al., 2006; Zhang et al., 2006; Buitrago et al.,
2012).
Vitamin D receptor has been identified in numerous
cardiovascular cell types including cardiomyocytes (Tishkoff
et al., 2008; Norman and Powell, 2014). Whereas experimental
studies have demonstrated rapid effects of calcitriol on cardiac
calcium channels (Zanatta et al., 2012; Tamayo et al., 2017), its
effects on cardiac potassium channels remain elusive. Thus, in
the present study we used patch-clamp recordings to examine
the rapid responses of calcitriol on the main K+ currents
responsible for cardiac repolarization in the mouse and the
potential mechanism (s) involved. Our results show that calcitriol
increases outward K+ current densities in ventricular myocytes
via Akt signaling, and that this mechanism can contribute to the
protective effect of vitamin D on the heart.
MATERIALS AND METHODS
Animals
Adult (2–3 months old) male C57BL/6J mice and VDR knockout
(KO) mice were originally generated by Dr. Marie Demay
(Harvard Medical School, Boston, MA, United States) (Li et al.,
1997) and kindly donated by Dr Alberto Muñoz (Biomedical
Research Institute “Alberto Sols” CSIC-UAM, Madrid, Spain)
were used. All experiments on mice were performed after
approval by the Bioethical Committee of the Consejo Superior
de Investigaciones Cientificas following recommendations of
the Spanish Animal Care and Use Committee (Proex 035-15)
according to the guidelines for ethical care of experimental
animals of the European Union (2010/63/EU).
Electrophysiological Procedures and
Data Analysis
Adult mouse ventricular cardiomyocytes were isolated as
described (Delgado et al., 2015). Single rod-shaped, Ca2+-
tolerant myocytes were treated with calcitriol or vehicle for 15–
30 min and used for electrophysiological recordings within 4 h of
isolation.
The electrophysiological protocols used to record APs and
K+ currents in this study were the same as those previously
described (Trépanier-Boulay et al., 2001; Brouillette et al., 2004;
Gómez-Hurtado et al., 2017). Briefly, ventricular myocytes were
placed in a chamber mounted on the stage of an inverted
microscope and allowed to adhere for 5 min before being
superfused with Tyrode’s solution. Whole-cell voltage-clamp and
current clamp recordings were obtained in the ruptured patch
configuration using an Axopatch 200B patch clamp amplifier
(Molecular Devices, Sunnyvale, CA, United States). The patch
pipette resistance was 1.0–2 M and the pipette was filled with
a solution containing (in mM): 135 KCl, 4 MgCl2, 5 EGTA,
10 HEPES, 10 glucose, 5 Na2ATP, and 5 disodium creatine
phosphate; the pH was adjusted to 7.2 with KOH. Whole-cell
voltage clamp experiments were performed at room temperature
(24–26◦C), whereas whole-cell current clamp experiments (AP
recordings) were carried out at 36–37◦C.
The external solution for K+ current recordings contained
(in mM): 135 NaCl, 10 glucose, 10 HEPES, 1 MgCl2, 1 CaCl2,
5.4 KCl, and 2 CoCl2; the pH was adjusted to 7.4 with NaOH.
The external solution for AP recordings contained (in mM): 140
NaCl, 10 glucose, 10 HEPES, 1.1 MgCl2, 1.8 CaCl2, and 4 KCl; the
pH was adjusted to 7.2 with NaOH.
Current density was calculated from the current amplitude
normalized to the membrane capacitance. Membrane
capacitance (Cm) was elicited by applying ±10 mV voltage
steps from −60 mV and Cm was calculated according to the
following equation:
Cm = τcI0/1Vm[1− (I∞/I0)]
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where τc is the time constant of the membrane capacitance, I0 the
maximum capacitance current value, 1Vm the amplitude of the
voltage step, and I∞ the amplitude of the steady-state current.
In some experiments the perforated patch-clamp technique
was used to record the time course of the effects of calcitriol
on total K+ currents. Perforated-patch recordings were started
5–25 min after a giga-seal was obtained. Just before use, the
tip of the pipette was filled with antibiotic-free intracellular
solution and the remainder of the pipette was backfilled
with pipette solution containing 250 µg/mL amphotericin B.
Depolarizing pulses from a holding potential of −60 to −40 mV
were used to monitor the access resistance. Recordings of
Itotal were initiated when the access resistance was stabilized
at 6–13 M. Itotal was elicited by depolarizing pulses to
+50 mV from a holding potential of −80 mV every 10 s.
The extracellular solution for Itotal recordings for perforated-
patch experiments was the same that we used for the whole-cell
experiments. The intracellular solution used to elicit recordings
in the perforated-patch configuration contained (in mM): 110
potassium aspartate, 20 KCl, 1 EGTA, 1 CaCl2, 5 HEPES, 1
MgCl2, 250 µg/mL amphotericin B; pH adjusted to 7.2 with
KOH.
Western Blotting
Cardiomyocytes were homogenized in a buffer containing
320 mM sucrose, 50 mM Tris and 0.2% nonidet P-40,
supplemented with a phosphatase, trypsin and protease inhibitor
cocktail (Sigma-Aldrich, Madrid, Spain). Lysed cells were
centrifuged at 13,000 rpm for 10 min at 4◦C and the supernatants
were used for immunoblotting. Equal amounts of protein
were separated on 10% SDS–PAGE gels and transferred to
polyvinylidene difluoride membranes. The membranes were
blocked with 5% non-fat milk and incubated overnight with
the following primary antibodies: phospho-Akt (Thr308) and
Akt (Cell Signaling Technology, Danvers, MA, United States).,
blots were incubated with peroxidase-conjugated secondary
antibodies and immunoreactive bands were detected using the
Amersham ECLTM protein detection system (GE Healthcare,
Piscataway, NJ, United States) and medical x-ray film blue
(Agfa HealthCare, Morstel, Belgium). Films were scanned with
a NIKON camera and quantified by ImageJ software (NIH,
Bethesda, MD, United States).
Reagents
The Akt inhibitor triciribine, calcitriol and amphotericin B
were purchased from Sigma-Aldrich Co. (St. Louis, MO,
United States). A stock solution of calcitriol was prepared using
DMSO as vehicle (<0.01% DMSO).
Statistical Analysis
Data are presented as means ± SEM. Statistical analysis
was performed with GraphPad Prism 5.0 (GraphPad Software
Inc., La Jolla, CA, United States). Statistical significance was
evaluated using unpaired or paired Student’s t-test when
appropriate. A value of P < 0.05 was considered statistically
significant.
RESULTS
Calcitriol Increases Outward K+ Currents
For the experimental setup, the main K+ currents responsible
for the AP repolarization phase in the mouse were recorded
in ventricular myocytes treated either with vehicle or 10 nM
calcitriol for 15–30 min. In the adult mouse ventricle, outward
K+ currents involved in cardiac repolarization comprise three
components that can be distinguished by their specific time and
voltage dependency and also their sensitivity to pharmacological
agents. Figure 1 illustrates the protocol used to identify the
three components: the fast transient outward current (Itof),
the ultrarapid delayed rectifier K+ current (Ikur) and the non-
inactivating steady-state outward current (Iss). As a first step the
total K+ currents were recorded by applying 300 ms depolarizing
steps from −50 to +50 mV from a holding potential of −80 mV
(Figure 1A). Then, Itof was inactivated by applying a short
prepulse (100 ms step at −30 mV) from a holding potential of
−80 mV, followed by depolarizing steps from −50 to +50 mV.
Itof was then calculated by substracting the current recording with
(Figure 1A) and without (Figure 1B) the inactivating prepulse.
The current that remains after Itof was inactivated, is composed
of Iss and IKur. To separate both currents, a low concentration of
4-aminopyridine (4-AP, 250 µM), which selectively blocks Ikur,
was applied to cells that were prepulsed to inactivate Itof. The
current remaining after this protocol is Iss (Figure 1C), and Ikur
can then be obtained by subtracting the current in the absence
(Figure 1B) and in the presence (Figure 1C) of 4-AP. Figure 2A
shows representatives recordings of total K+ currents obtained
in 1 myocyte treated with vehicle and in 1 myocyte treated with
10 nM calcitriol. Figure 2B shows mean current-voltage (IV)
curves for Itotal density. Myocytes treated with calcitriol showed
higher values of Itotal density than those treated with vehicle (at
+50 mV, vehicle 38.2 ± 2.2 pA/pF, n = 27; calcitriol 50.5 ± 3.1
pA/pF, n = 30; P < 0.01). In another group of experiments we
tested the effect of calcitriol on total K+ currents by analyzing
the time dependence of the effect in continuous recordings.
For that, we used the perforated patch-clamp technique which
preserves the cell from loss of some cytosolic second messengers
due to intracellular dialysis that occurs during prolonged whole-
cell recordings. Figure 2C (upper panel) shows representative
traces of Itotal corresponding to points a, b, and c on the graph
below (lower panel). Peak Itotal was elicited by depolarizing pulses
from a holding potential of −80 to +50 mV every 10 s over
19 min. Application of calcitriol induced a rapid increase in
Itotal, which reached a maximum effect at 9–10 min; then, the
cardiomyocyte was perfused with calcitriol-free solution, which
led to a progressive decrease in Itotal toward control values after
∼10 min of washout. Similar results were obtained in three other
cardiomyocytes.
Figure 3A (left panel) shows representative recordings of Itof
obtained in 1 myocyte treated with vehicle and in 1 myocyte
treated with 10 nM calcitriol a, and Figure 3A (right panel)
shows (IV) curves for Itof density. Myocytes treated with calcitriol
showed higher values of Itof density than those treated with
vehicle (at +50 mV, vehicle: 10.6. ± 0.9 pA/pF, n = 23; calcitriol:
15.9 ± 1.4 pA/pF, n = 28; P < 0.01). Figure 3B (left panel)
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illustrates representative recordings of Ikur obtained in 1 myocyte
treated with vehicle and in 1 myocyte treated with 10 nM
calcitriol l), Figure 3B (right panel) shows mean IV curves for
Ikur density). Myocytes treated with calcitriol showed higher
values of Ikur density than those treated with vehicle (at+50 mV,
vehicle: 13.2 ± 1.2 pA/pF, n = 25; calcitriol: 19.4 ± 1.8 pA/pF,
n = 24; P < 0.01). Representative recordings of Iss obtained
in 1 myocyte treated with vehicle and in 1 myocyte treated
with 10 nM calcitriol are shown in Figure 3C left panel,
and mean IV curves for Iss density are shown in Figure 3C
right panel. Iss values in myocytes treated with vehicle (at
+50 mV, 12.4 ± 0.8 pA/pF, n = 12) were similar to those of
myocytes treated with calcitriol (at +50 mV, 12.8 ± 0.5 pA/pF,
n = 26).
Calcitriol Treatment Does Not Modify
Action Potentials Duration
Since an increase in outward current can modulate
repolarization, we carried out current clamp experiments
to measure AP duration (APD) in myocytes treated with
vehicle or calcitriol. Representative traces of APs recorded in 1
ventricular myocyte treated with vehicle (left) and in 1 myocyte
treated with calcitriol (right) are shown in Figure 4A. Mean
values of APD measured at 20, 50, and 90% of repolarization
obtained in ventricular myocytes treated with vehicle or calcitriol
are illustrated in Figure 4B. Values of APD were similar in both
groups: APD20, vehicle 1.2 ± 0.6 ms vs. calcitriol 1.3 ± 0.1 ms;
APD50, vehicle 3.4 ± 0.3 ms vs. calcitriol 2.9 ± 0.2 ms;
APD90, vehicle 25.2 ± 3.5 ms vs. calcitriol 23.5 ± 2.5 ms
(n = 10 cells treated with vehicle or calcitriol). In addition,
no differences were observed in resting potential (RP) or AP
amplitude in myocytes treated with vehicle or with calcitriol
(−78.3± 1.9 mV vs.−77.4± 1.4 mV for RP and 117.7± 3.7 mV
vs. 120.7± 3.6 mV for AP amplitude, vehicle vs. calcitriol-treated
cells, respectively).
Vitamin D Receptor Is Involved in the
Effect of Calcitriol on Outward K+
Currents
To examine the participation of VDR in the effect of calcitriol
on Itof and Ikur, ventricular myocytes were isolated from VDR-
KO mice and treated with vehicle or 10 nM calcitriol for 15–
30 min. Representative recordings of Itof, obtained in 1 VDR-KO
myocyte treated with vehicle or 10 nM calcitriol are shown in
Figure 5A left panel, and mean IV curves for Itof density are
shown in Figure 5A right panel. In VDR-deficient myocytes,
calcitriol was unable to increase Itof density when compared
with vehicle (at +50 mV, vehicle: 13.1 ± 1.8 pA/pF, n = 10;
calcitriol: 12.5 ± 2.2 pA/pF, n = 6). Representative recordings
of Ikur, obtained in 1 VDR-KO myocyte treated with vehicle
and in 1 VDR-KO myocyte treated with 10 nM calcitriol are
shown in Figure 5B (left panel), and mean IV curves for Ikur
density are shown in Figure 5B right panel. In the absence of
VDR, the mean Ikur density was similar between myocytes treated
FIGURE 1 | Protocol used to isolate the fast transient outward K+ current (Itof), the ultrarapid delayed rectifier K+ current (Ikur) and the non-inactivating steady-state
outward current (Iss) in mouse ventricular cardiomyocytes. (A) Superimposed current records of total K+ currents activated by voltage protocol shown on the left.
(B) Family of K+ currents obtained from the same cell as in (A) (Cm = 212 pF), but voltage-clamp steps were each preceded by an inactivating pulse at −30 mV,
shown in the left panel. Itof was then calculated by substracting the current recording with (A) and without (B) the inactivating prepulse. (C) Superimposed current
records of K+ currents obtained after the same cell as those in (B) (Cm = 212 pF) was perfused with 4-AP, which selectively blocks IKur. The current remaining after
this protocol is Iss, and Ikur was then obtained by subtracting the current in the absence and in the presence of 4-AP.
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FIGURE 2 | Calcitriol increases total K+ currents in ventricular myocytes. (A) Superimposed current records of total K+ current (Itotal) for 1 myocyte treated with
vehicle and 1 myocyte treated with 10 nM calcitriol. (B) Current-voltage curves for Itotal density obtained in myocytes treated with vehicle or calcitriol. (C) Time course
of the effect of calcitriol on Itotal by perforated patch-clamp recordings. The black points in the figure are peak outward currents recorded at +50 mV every 10 s.
Horizontal line indicates exposure to calcitriol 10 nM and washout. Upper panel shows Itotal traces at +50 mV corresponding to time 0 min (a), 9 min after calcitriol
perfusion (b), and ∼10 min after washout (c). Data are expressed as means ± SEM. Cm = membrane capacitance in pF. ∗∗∗P < 0.001; ∗∗P < 0.01; ∗P < 0.05.
with vehicle or calcitriol (at +50 mV, vehicle: 9.9 ± 1.0 pA/pF,
n = 6; calcitriol: 11.2 ± 1.4 pA/pF, n = 9). Representative
recordings of Iss, obtained in 1 VDR-KO myocyte treated with
vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol
are shown in Figure 5C (left panel), and mean IV curves for Iss
density in VDR-KO myocytes treated with vehicle or calcitriol are
Frontiers in Physiology | www.frontiersin.org 5 August 2018 | Volume 9 | Article 1186
fphys-09-01186 August 23, 2018 Time: 17:51 # 6
Tamayo et al. Calcitriol Increases K+ Currents in Cardiomyocytes
FIGURE 3 | The fast transient outward K+ current (Itof) and the ultrarapid delayed rectifier K+ current (Ikur) are significantly increased in calcitriol-treated myocytes.
(A) Left panel: representative Itof traces for 1 myocyte treated with vehicle and 1 myocyte treated with 10 nM calcitriol. Right panel: I/V curves for Itof density obtained
in myocytes treated with vehicle or with 10 nM calcitriol. (B) Left panel: representative Ikur traces for 1 myocyte treated with vehicle and 1 myocyte treated with
calcitriol. Right panel: I/V curves for Ikur density obtained in myocytes treated with vehicle or calcitriol. (C) Left panel: representative Iss traces for 1 myocyte treated
with vehicle and 1 myocyte treated with calcitriol. Right panel: IV curves for Issx densities obtained in myocytes treated with vehicle or with calcitri. Data are
expressed as means ± SEM. Cm = membrane capacitance in pF. ∗∗∗P < 0.001; ∗∗P < 0.01; ∗P < 0.05.
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FIGURE 4 | Effects of calcitriol on Action Potentials Duration (A) Representative traces of action potentials recorded in 1 myocyte treated with vehicle and in 1
myocyte treated with 10 nM calcitriol. (B) Bar graph showing mean action potential duration (APD) values measured at 20, 50, and 90% of repolarization (APD20,
APD50, and APD90, respectively). Data are expressed as means ± SEM.
shown in Figure 5C right panel. Results showed that calcitriol
had no effect on Iss density in VDR-KO myocytes (at +50 mV,
vehicle: 8.7 ± 0.6 pA/pF, n = 13; calcitriol: 8.8 ± 0.6 pA/pF,
n = 10).
Akt Mediates the Stimulatory Effect of
Calcitriol on Itof and Ikur
It has been postulated that the activation of the PI3K pathway
can modulate cardiac K+ channels (Yang et al., 2012; Gomez-
Hurtado et al., 2014). To explore the implication of PI3K
signaling in the calcitriol-induced increase of Itof and Ikur
densities, we questioned whether calcitriol activates Akt, a known
target of PI3K, in ventricular myocytes (Shioi et al., 2002;
McMullen et al., 2003). We observed a significant activation of
Akt (measured as phosphorylation) after 15 min of calcitriol
treatment (Figures 6A,B). We therefore measured Itof, Ikur, and
Iss in myocytes pretreated with 1 µM of the Akt inhibitor
triciribine. Representative traces obtained in myocytes pretreated
with triciribine and then treated with vehicle or calcitriol are
shown in Figures 7A–C, respectively (left panels), and mean
IV curves for Itof, Ikur and Iss densities in both situations are
shown in the corresponding right panels. The results showed
that treatment with triciribine prevented the stimulatory effect of
calcitriol on Itof and IKur.
DISCUSSION
Cardiac APs are the consequence of the coordinated functioning
of inward and outward current flowing through specialized
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FIGURE 5 | Effect of calcitriol on Itof and Ikur involves binding to the vitamin D receptor. (A) Left panel: representative traces of Itof obtained in 1 VDR-KO myocyte
treated with vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol. Right panel: I/V curves for Itof density obtained in VDR-KO myocytes treated with vehicle
or calcitriol. (B) Left panel: representative traces of Ikur obtained in 1 VDR-KO myocyte treated with vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol.
Right panel: I/V curves for Ikur density obtained in VDR-KO myocytes treated with vehicle or calcitriol. (C) Left panel: representative traces of Iss obtained in 1
VDR-KO myocyte treated with vehicle and in 1 VDR-KO myocyte treated with 10 nM calcitriol. Right panel: I/V curves for Iss density obtained in VDR-KO myocytes
treated with vehicle or calcitriol. Data are expressed as means ± SEM. Cm = membrane capacitance in pF.
proteins (ionic channels) that open and close in a voltage- and
time-dependent manner allowing rhythmic and effective cardiac
contractions (Gaborit et al., 2007). It is well known that K+
current density is reduced during heart remodeling under various
pathological conditions including left ventricular hypetrophy
and HF. This process is associated with prolonged QT interval,
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FIGURE 6 | Calcitriol activates the Akt pathway in ventricular myocytes.
Ventricular myocytes were exposed to vehicle or calcitriol 10 nM for 15 min.
(A) Representative western blot and (B) average ratio of protein levels
expressed as the percentage of phospho (P)-Akt normalized to total Akt. Data
are expressed as mean ± SEM. ∗P < 0.05.
increased risk of malignant arrhythmias and sudden cardiac
death (Ravens and Cerbai, 2008). Here, we tested the hypothesis
that calcitriol might have a cardioprotective effect by increasing
K+ currents, thereby circumventing inappropriate prolongation”
of the APD during pathology. In mice, the repolarization phase
of the AP is determined principally by the outward currents
Itof and Ikur, which account for the remarkably abbreviated APs
and the absence of a clear plateau phase in this species. We
found that calcitriol significantly increased Itof and Ikur densities.
In apparent contrast, we found that the APD was similar in
myocytes treated or not with calcitriol. The lack of the effect of
increased K+ currents on the APD in calcitriol-treated myocytes
indicates that calcitriol might affect other ionic currents that
influence the APD. In this sense, we previously demonstrated
that calcitriol can increase L-type calcium current (ICaL) density
in ventricular myocytes (Tamayo et al., 2017). The increase
of ICaL might counterbalance the effect of increased outward
K+ currents in calcitriol-treated myocytes, preserving the APD.
Calcitriol can induce genomic (transcription-dependent) and
non-genomic (transcription-independent) actions. Indeed, there
is a general agreement in the idea that calcitriol effects observed
within minutes (such as those described in the present study)
involve only non-genomic effects mediated by extra-nuclear
mechanisms (Mizwicki and Norman, 2009). Most calcitriol
actions are mediated by VDR. Classic nuclear VDR is required
for genomic effects, whereas non-genomic actions are thought
to be mediated by a fraction of VDR located in the cytosol
or at the plasma membrane (Norman et al., 2001a,b). In this
regards, in silico studies have been useful to determine exactly
how calcitriol binds to VDR to regulate both genomic and non-
genomic responses. An alternative ligand-binding pocket has
been identified in VDR that specifically mediates non-genomic
actions and that partially overlaps the genomic pocket described
in the experimentally determined x-ray structure (Mizwicki
et al., 2004). In the present study, we used VDR-KO mice to
determine whether the effect of calcitriol on K+ currents in
cardiomyocytes involves VDR. Our results clearly show that
the absence of VDR abolished all changes in K+ currents
induced by the acute administration of calcitriol, demonstrating
that these effects are VDR-dependent. Consistent with this, we
have previously described that calcitriol exerts VDR-dependent
non-genomic effects on Ca2+ current and PKA signaling in
cardiomyocytes (Tamayo et al., 2017), which is in line with
the findings by Zanello and Norman (2006) showing that a
functional VDR is required for the rapid increase in Cl- current
and for the shift in the peak activation of ICaL current induced
by calcitriol in osteoblasts. As VDR-KO mice do not express
VDR, this model does not allow us to discriminate precisely
which VDR location mediates these observed effects. We are,
however, inclined to favor a non-genomic action mediated by
membrane VDR due to the short time required (15–30 min)
and the fact that VDR has been reported to be expressed in the
tubular system of ventricular myocytes (Tishkoff et al., 2008),
a region where voltage-gated calcium and potassium channels
are predominantly localized (Takeuchi et al., 2000; Brette and
Orchard, 2003). On the other hand, protein disulfide isomerase
family A member 3 (PDIA3) has been proposed as a membrane
receptor for calcitriol that mediates some of its non-genomic
effects in chondrocytes, osteoblasts and other cell types (Boyan
et al., 2003; Doroudi et al., 2014a,b). Intriguingly, both PDIA3
and VDR are located in caveolae in many tissues and cell types,
and an interaction between them has been observed, suggesting
that VDR and PDIA3 might both be required for some non-
genomic actions of calcitriol (Sequeira et al., 2012; Chen et al.,
2013). As the effects of calcitriol on K+ current in cardiomyocytes
are completely abolished in VDR-KO cells we would argue
that PDIA3 is not implicated in the described effect, although
clearly experiments with PDIA3-KO cells would be necessary to
completely discard the possibility that both VDR and PDIA3 are
involved.
Several reports have shown that calcitriol binding to
plasma membrane VDR induces rapid non-transcriptional
responses through the activation of different signaling
pathways including PI3K/Akt (Buitrago et al., 2012; Salles
et al., 2013). This pathway is widely expressed in eukaryotes
and is known to play key roles in growth, differentiation,
proliferation, and survival (Cantley, 2002). In the heart,
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FIGURE 7 | Inhibition of Akt signaling prevents the increase in Itof and Ikur densities induced by calcitriol. (A) Left panel: Itof traces obtained in 1 myocyte treated with
1 µM triciribine and in 1 myocyte treated with 1 µM triciribine plus 10 nM calcitriol. Right panel: I/V curves for Itof density obtained in myocytes treated with 1 µM
triciribine or with triciribine plus 10 nM calcitriol. (B) Left panel: Ikur traces obtained in one myocyte treated with 1 µM triciribine and in 1 myocyte treated with 1 µM
triciribine plus 10 nM calcitriol. Right panel: I/V curves for Ikur density obtained in myocytes treated with 1 µM triciribine or with triciribine plus 10 nM calcitriol. (C) Left
panel: Iss traces obtained in 1 myocyte treated with 1 µM triciribine and in 1 myocyte treated with 1 µM triciribine plus 10 nM calcitriol. Right panel: I/V curves for Iss
density obtained in myocytes treated with 1 µM triciribine or with triciribine plus 10 nM calcitriol. Data are expressed as means ± SEM. Cm, membrane capacitance;
TCB, triciribine.
PI3K/Akt activation has been related to both physiological
cardiac enlargement and protection (McMullen et al.,
2003; Weeks et al., 2012). Moreover, it is believed that the
PI3K/Akt pathway might regulate cardiac ion channels and
arrhythmogenesis (Ballou et al., 2015). Our results show that
calcitriol activates Akt in adult ventricular myocytes, and
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its pharmacological inhibition prevents the calcitriol-induced
increase of Itof and Ikur densities.
In sum, we demonstrate that calcitriol binding to VDR
increases the density of the two main K+ currents responsible
for the rapid repolarization of the AP in the mouse, Itof and IKur.
Our study also supports a role of Akt signaling in this stimulatory
effect.
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